Commentary on the European Medicines Agency's extended mandate: Protecting public health in times of crisis and improving availability of medicines and medical devices

por Abed, Inga, Gonzalez‐Quevedo, Rosa, Mura, Manuela, Dias, Monica, da Rocha Dias, Silvy, García Burgos, Juan
Publicado 2022

European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with int...

por Ali, Sahra, Camarero, Jorge, van Hennik, Paula, Bolstad, Bjorg, Sommerfelt Grønvold, Maja, Syvertsen, Christian, Oddvar Strøm, Bjorn, Ökvist, Mats, Josephson, Filip, Keller-Stanislawski, Brigitte, Zafiropoulos, Nikolaos, Pean, Elias, Bergh, Jonas, da Rocha Dias, Silvy, Pignatti, Franscesco
Publicado 2020

Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers

por Lyerly, H. Kim, Ren, Jun, Canetta, Renzo, Kim, Gi Hyun, Nagai, Sumimasa, Yamaguchi, Tomohiro, Hatogai, Ken, Katayama, Hiroshi, Da Rocha Dias, Silvy, McManus, Daniel, Soltys, Kathy, Yang, Zhimin, Olopade, Olufumilayo, Goodman, Nancy, Reaman, Greg, Gross, Thomas
Publicado 2018